Transaction · 0001274737-25-000011

Black Jeffrey G.

Black Jeffrey G., CFO, reported a transaction classified as grant at EXAGEN INC. involving 15000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 289492.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
XGNEXAGEN INC.
Filing timeFeb 26
Trade dateFeb 21, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

XGN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
XGN since 2025-02-26Filed 554 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001274737-25-000011
Common Stock
Transaction date
Feb 21, 2025
Filed Feb 26, 2025, 01:59 AM · 5d delay
Shares
15.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
289k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issu…

  2. F2

    The option is exercisable as it vests. 25% of the shares subject to the option vest on February 21, 2026, and 1/48th of the total number of shares subject to the option vest at the end of each calenda…

Original filing · 0001274737-25-000011
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

XGN